Preferred Label : vilobelimab;

MeSH synonym : CACP 29;

UNII : F5T0RF9ZJA;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.ema.europa.eu/en/medicines/human/EPAR/gohibic
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
vilobelimab
vilobelimab
drug approval
europe
vilobelimab
antibodies, monoclonal
antibodies, monoclonal
complement inactivating agents
complement inactivating agents
COVID-19
COVID-19-Associated Acute Respiratory Distress Syndrome
Respiratory Distress Syndrome
infusions, intravenous
product surveillance, postmarketing
complement C5a
adult
drug evaluation, preclinical
pregnancy
breast feeding

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.